SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001439222-21-000073
Filing Date
2021-11-03
Accepted
2021-11-03 13:08:42
Documents
70
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q agio-20210930.htm   iXBRL 10-Q 1680799
2 EX-10.1 exhibit1019-30x21bowdenchr.htm EX-10.1 6238
3 EX-10.2 exhibit1029-30x2138sidneys.htm EX-10.2 83107
4 EX-31.1 exhibit31-1x09x30x21.htm EX-31.1 9844
5 EX-31.2 exhibit31-2x09x30x21.htm EX-31.2 9863
6 EX-32.1 exhibit32-1x09x30x21.htm EX-32.1 4841
7 EX-32.2 exhibit32-2x09x30x21.htm EX-32.2 4844
13 image_0.jpg GRAPHIC 96462
  Complete submission text file 0001439222-21-000073.txt   7076842

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT agio-20210930.xsd EX-101.SCH 36048
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT agio-20210930_cal.xml EX-101.CAL 86653
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT agio-20210930_def.xml EX-101.DEF 197338
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT agio-20210930_lab.xml EX-101.LAB 521958
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT agio-20210930_pre.xml EX-101.PRE 367784
14 EXTRACTED XBRL INSTANCE DOCUMENT agio-20210930_htm.xml XML 1163630
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36014 | Film No.: 211374584
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences